Giampiero Spalluto

Title: Giampiero Spalluto: Innovator in Fluorescent Antagonists

Introduction

Giampiero Spalluto is a notable inventor based in Ferrara, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the development of fluorescent antagonists for the A3 adenosine receptor. With a total of 2 patents to his name, Spalluto's work has implications for both diagnostics and therapeutic treatments.

Latest Patents

One of his latest patents involves the creation of fluorescent antagonists of the A3 adenosine receptor. This patent discloses compounds of a specific formula that serve as fluorescently labeled antagonists. The compounds are designed for use in diagnostic compositions and methods for diagnosing patients who may benefit from treatment involving these antagonists. Another patent focuses on benzoheterocyclic distamycin derivatives and the processes for preparing them, showcasing his innovative approach to drug development.

Career Highlights

Throughout his career, Giampiero Spalluto has worked with prominent organizations, including Pharmacia & Upjohn S.p.a. and the National Institutes of Health, which is a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to contribute to significant advancements in pharmaceutical research.

Collaborations

Spalluto has collaborated with esteemed colleagues such as Paolo Cozzi and Pier Giovanni Baraldi. These partnerships have enriched his research and expanded the impact of his inventions in the scientific community.

Conclusion

Giampiero Spalluto's innovative work in the field of medicinal chemistry, particularly with fluorescent antagonists, highlights his role as a key inventor. His contributions continue to influence the development of diagnostic and therapeutic solutions.